Home LiteratureArticle Details
PMID: 8978697 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivo.

The EMBO journal ·Vol. 15 ·No. 23 ·1996-12-02 ·Pages 6716-26

Krappmann D, Wulczyn FG, Scheidereit C

Abstract

The transcription factor NF-kappaB is sequestered in the cytoplasm by a family of IkappaB molecules. Upon cellular stimulation with diverse agents, one of these molecules, IkappaB alpha, is rapidly phosphorylated and subsequently degraded. This process triggers nuclear translocation of NF-kappaB and the successive activation of target genes. Independent of its rapid stimulation-induced breakdown, IkappaB alpha is inherently unstable and undergoes a continuous turnover. To compare the mechanisms and protein domains involved in inducible and basal degradation of IkappaB alpha in intact cells we employed a transfection strategy using tagged IkappaB alpha and ubiquitin molecules. We show that tumor necrosis factor alpha (TNFalpha) induced breakdown of IkappaB alpha but not its basal turnover coincides with ubiquitination in the amino-terminal signal response domain (SRD) of IkappaB alpha. Neither the SRD nor the carboxy-terminal PEST sequence is needed for basal turnover, which instead depends only on the core ankyrin repeat domain. Despite the differences in the requirements of protein domains and ubiquitin-conjugation for both degradation pathways, each one is mediated by the proteasome. This finding is important for understanding alternative modes of controlling NF-kappaB activity.

MeSH Terms
Animals Blotting, Western COS Cells Cysteine Endopeptidases/metabolism DNA-Binding Proteins/biosynthesis,metabolism HeLa Cells Humans I-kappa B Proteins Models, Biological Multienzyme Complexes/metabolism NF-KappaB Inhibitor alpha NF-kappa B/antagonists & inhibitors Proteasome Endopeptidase Complex Proto-Oncogene Proteins c-jun/metabolism Recombinant Proteins/biosynthesis,metabolism Signal Transduction Transfection Ubiquitins/metabolism
Chemicals
DNA-Binding Proteins I-kappa B Proteins Multienzyme Complexes NF-kappa B NFKBIA protein, human Proto-Oncogene Proteins c-jun Recombinant Proteins Ubiquitins NF-KappaB Inhibitor alpha Cysteine Endopeptidases Proteasome Endopeptidase Complex
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Krappmann D
Max-Delbrück-Center for Molecular Medicine MDC, Berlin, Germany.
Wulczyn F G
Scheidereit C
References (62)
62 references, click to expand
  1. Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation.
    Mol Cell Biol. 1996 Apr;16(4):1295-304 PMID: 8657102
  2. Constitutive phosphorylation of I kappa B alpha by casein kinase II.
    Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7637-41 PMID: 7644469
  3. The ankyrin repeats but not the PEST-like sequences are required for signal-dependent degradation of IkappaBalpha.
    Oncogene. 1996 Mar 7;12(5):1159-64 PMID: 8649809
  4. Constitutive phosphorylation of IkappaBalpha by casein kinase II occurs preferentially at serine 293: requirement for degradation of free IkappaBalpha.
    Mol Cell Biol. 1996 Jul;16(7):3554-9 PMID: 8668171
  5. In vivo stimulation of I kappa B phosphorylation is not sufficient to activate NF-kappa B.
    Mol Cell Biol. 1995 Mar;15(3):1294-301 PMID: 7862123
  6. Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis.
    Science. 1986 Oct 17;234(4774):364-8 PMID: 2876518
  7. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism.
    Cell. 1986 Dec 26;47(6):921-8 PMID: 3096580
  8. Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity.
    Cell. 1991 Jun 28;65(7):1281-9 PMID: 1829648
  9. Direct association of pp40/I kappa B beta with rel/NF-kappa B transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity.
    Proc Natl Acad Sci U S A. 1992 May 15;89(10):4333-7 PMID: 1533932
  10. The NF-kappa B precursor p105 and the proto-oncogene product Bcl-3 are I kappa B molecules and control nuclear translocation of NF-kappa B.
    EMBO J. 1993 Jan;12(1):213-22 PMID: 8428580
  11. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway.
    Science. 1993 Mar 26;259(5103):1912-5 PMID: 8096091
  12. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation.
    Mol Cell Biol. 1993 Jun;13(6):3301-10 PMID: 8497253
  13. Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-Rel and related NF-kappa B proteins in human monocytic THP-1 cells.
    J Biol Chem. 1993 Jun 5;268(16):11803-10 PMID: 8505309
  14. The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms.
    Genes Dev. 1993 Jul;7(7A):1266-76 PMID: 8319912
  15. Cytokine-inducible expression in endothelial cells of an I kappa B alpha-like gene is regulated by NF kappa B.
    EMBO J. 1993 Jul;12(7):2773-9 PMID: 8334993
  16. Common structural constituents confer I kappa B activity to NF-kappa B p105 and I kappa B/MAD-3.
    EMBO J. 1993 Jul;12(7):2781-8 PMID: 8334994
  17. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B.
    Nature. 1993 Sep 9;365(6442):182-5 PMID: 8371761
  18. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation.
    Science. 1995 Mar 10;267(5203):1485-8 PMID: 7878466
  19. Structure, regulation and function of NF-kappa B.
    Annu Rev Cell Biol. 1994;10:405-55 PMID: 7888182
  20. In vivo control of NF-kappa B activation by I kappa B alpha.
    EMBO J. 1993 Dec;12(12):4685-95 PMID: 8223478
  21. The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors.
    Genes Dev. 1993 Nov;7(11):2064-70 PMID: 8224838
  22. Proteolytic degradation of MAD3 (I kappa B alpha) and enhanced processing of the NF-kappa B precursor p105 are obligatory steps in the activation of NF-kappa B.
    Nucleic Acids Res. 1993 Nov 11;21(22):5059-66 PMID: 8255759
  23. Promoter analysis of the gene encoding the I kappa B-alpha/MAD3 inhibitor of NF-kappa B: positive regulation by members of the rel/NF-kappa B family.
    EMBO J. 1993 Dec 15;12(13):5043-9 PMID: 8262046
  24. Enhanced I kappa B alpha degradation is responsible for constitutive NF-kappa B activity in mature murine B-cell lines.
    Mol Cell Biol. 1994 May;14(5):3276-82 PMID: 8164680
  25. Function and activation of NF-kappa B in the immune system.
    Annu Rev Immunol. 1994;12:141-79 PMID: 8011280
  26. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B.
    Cell. 1994 Sep 9;78(5):773-85 PMID: 8087845
  27. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain.
    Cell. 1994 Sep 9;78(5):787-98 PMID: 8087846
  28. Activation of NF-kappa B in vivo is regulated by multiple phosphorylations.
    EMBO J. 1994 Oct 3;13(19):4597-607 PMID: 7925300
  29. Three NF-kappa B sites in the I kappa B-alpha promoter are required for induction of gene expression by TNF alpha.
    Nucleic Acids Res. 1994 Sep 11;22(18):3787-92 PMID: 7937093
  30. A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B.
    EMBO J. 1994 Nov 15;13(22):5433-41 PMID: 7957109
  31. Inducible phosphorylation of I kappa B alpha is not sufficient for its dissociation from NF-kappa B and is inhibited by protease inhibitors.
    Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):11884-8 PMID: 7991551
  32. Tumor necrosis factor alpha-induced phosphorylation of I kappa B alpha is a signal for its degradation but not dissociation from NF-kappa B.
    Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12740-4 PMID: 7809113
  33. The PEST-like sequence of I kappa B alpha is responsible for inhibition of DNA binding but not for cytoplasmic retention of c-Rel or RelA homodimers.
    Mol Cell Biol. 1995 Feb;15(2):872-82 PMID: 7823953
  34. Activation of NF-kappa B requires proteolysis of the inhibitor I kappa B-alpha: signal-induced phosphorylation of I kappa B-alpha alone does not release active NF-kappa B.
    Proc Natl Acad Sci U S A. 1995 Jan 17;92(2):552-6 PMID: 7831327
  35. The ubiquitin-mediated proteolytic pathway: mechanisms of action and cellular physiology.
    Biol Chem Hoppe Seyler. 1994 Sep;375(9):565-81 PMID: 7840898
  36. Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B.
    Mol Cell Biol. 1995 Mar;15(3):1302-11 PMID: 7862124
  37. NF-kappa B: a lesson in family values.
    Cell. 1995 Feb 24;80(4):529-32 PMID: 7867060
  38. I kappa B-beta regulates the persistent response in a biphasic activation of NF-kappa B.
    Cell. 1995 Feb 24;80(4):573-82 PMID: 7867065
  39. Ubiquitin-mediated processing of NF-kappa B transcriptional activator precursor p105. Reconstitution of a cell-free system and identification of the ubiquitin-carrier protein, E2, and a novel ubiquitin-protein ligase, E3, involved in conjugation.
    J Biol Chem. 1995 Sep 15;270(37):21707-14 PMID: 7665588
  40. Inactivation of NF-kappa B inhibitor I kappa B alpha: ubiquitin-dependent proteolysis and its degradation product.
    Biochem Biophys Res Commun. 1995 Oct 4;215(1):292-301 PMID: 7575604
  41. N- and C-terminal sequences control degradation of MAD3/I kappa B alpha in response to inducers of NF-kappa B activity.
    Mol Cell Biol. 1995 Oct;15(10):5339-45 PMID: 7565683
  42. Mechanistic aspects of NF-kappa B regulation: the emerging role of phosphorylation and proteolysis.
    Immunity. 1995 Sep;3(3):263-72 PMID: 7552992
  43. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway.
    Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10599-603 PMID: 7479848
  44. Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination.
    Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11259-63 PMID: 7479976
  45. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.
    Genes Dev. 1995 Nov 15;9(22):2723-35 PMID: 7590248
  46. Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice.
    Genes Dev. 1995 Nov 15;9(22):2736-46 PMID: 7590249
  47. Critical role for lysines 21 and 22 in signal-induced, ubiquitin-mediated proteolysis of I kappa B-alpha.
    J Biol Chem. 1996 Jan 5;271(1):376-9 PMID: 8550590
  48. Casein kinase II phosphorylates I kappa B alpha at S-283, S-289, S-293, and T-291 and is required for its degradation.
    Mol Cell Biol. 1996 Mar;16(3):899-906 PMID: 8622692
  49. Both amino- and carboxyl-terminal sequences within I kappa B alpha regulate its inducible degradation.
    Mol Cell Biol. 1996 Mar;16(3):1058-65 PMID: 8622650
  50. Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity.
    Cell. 1996 Mar 22;84(6):853-62 PMID: 8601309
  51. Role of IkappaBalpha ubiquitination in signal-induced activation of NFkappaB in vivo.
    J Biol Chem. 1996 Mar 29;271(13):7844-50 PMID: 8631829
  52. High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells.
    Blood. 1996 May 15;87(10):4340-7 PMID: 8639794
  53. Cactus protein degradation mediates Drosophila dorsal-ventral signaling.
    Genes Dev. 1995 Apr 1;9(7):783-93 PMID: 7705656
  54. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin.
    Science. 1995 May 5;268(5211):726-31 PMID: 7732382
  55. Inducible degradation of I kappa B alpha in vitro and in vivo requires the acidic C-terminal domain of the protein.
    Mol Cell Biol. 1995 May;15(5):2413-9 PMID: 7739525
  56. Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation.
    Mol Cell Biol. 1995 May;15(5):2809-18 PMID: 7739562
  57. Ubiquitinylation is not an absolute requirement for degradation of c-Jun protein by the 26 S proteasome.
    J Biol Chem. 1995 May 12;270(19):11623-7 PMID: 7744802
  58. Overexpression of RelA in transgenic mouse thymocytes: specific increase in levels of the inhibitor protein I kappa B alpha.
    Mol Cell Biol. 1995 Jul;15(7):3523-30 PMID: 7791759
  59. Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli.
    EMBO J. 1995 Jun 15;14(12):2876-83 PMID: 7796813
  60. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway.
    Genes Dev. 1995 Jul 1;9(13):1586-97 PMID: 7628694
  61. A role for phosphorylation and degradation in the control of NF-kappa B activity.
    Trends Genet. 1995 Jun;11(6):203-5 PMID: 7638895
  62. Phosphorylation of IkappaBalpha in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability.
    Mol Cell Biol. 1996 Apr;16(4):1401-9 PMID: 8657113
Article Info
Journal
The EMBO journal
Abbr.
EMBO J
ISSN
0261-4189
Published
1996-12-02
Pages
6716-26
Language
English
Region
England
NLM ID
8208664
PMCID
PMC452495
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]